Psychiatry
Alzheimer's Disease
More in Alzheimer's Disease
News and commentary from the psychiatry world
News and commentary from the psychiatry world
Patients starting SSRIs and lecanemab may warrant close monitoring
Inclusion and exclusion criteria whittle down pool of eligible treatment candidates
"Patients will have a difficult time knowing what the results mean"
Aims to provide more coordinated, ongoing care
Also in TTHealthWatch: a new monoclonal for Alzheimer's, and vaccinating moms for group B strep
Without biomarkers, primary care doctors correctly identified Alzheimer's in about 55% of cases
Despite equal access to care, health inequalities persisted in disadvantaged areas
Hearing loss is more than a marker for dementia risk, it appears
Safety issues linger, as details of three deaths emerge
A ray of hope amidst disappointing results from A4 trial
